Matches in SemOpenAlex for { <https://semopenalex.org/work/W2519495511> ?p ?o ?g. }
- W2519495511 endingPage "432" @default.
- W2519495511 startingPage "425" @default.
- W2519495511 abstract "Background Pulmonary hypertension (PH) is a serious disease, and treatment is a continuing challenge. Some in vitro and in vivo studies identified that statins were effective for PH. However, results of some randomised controlled trials (RCTs) have been controversial. The objective of our study was to clarify whether statins are effective and safe for pulmonary hypertension. Methods We systematically searched for eligible RCTs from PubMed, EMBASE, Web of Science, and the Cochrane Library during January 2016. Two reviewers independently extracted data. Standard mean differences (SMDs) and weighted mean differences (WMDs) with 95% confidence intervals (CIs) were estimated for continuous data (exercise capacity cardiac, pulmonary arterial pressure (PAP), cardiac index, and low-density lipoprotein (LDL)). Risk ratios (RRs) were estimated for dichotomous data (adverse events and clinical deterioration). Results A total of 496 patients from six RCTs were included. Low-density lipoprotein in the statin group decreased significantly compared with the placebo group (WMD = -22.79; 95% CI: -34.33 ∼ -11.24). However, we did not find a statistically significant effect on exercise capacity (SMD = 0.18; 95% CI: -0.34 - 0.71), PAP (WMD = -3.01; 95% CI: -8.68 - 2.65), or CI (WMD = -0.04; 95% CI: -0.15 - 0.23). Additionally, there was no difference between statins and placebo with respect to hepatic injury (RR: 1.12; 95% CI: 0.43 - 2.92), myalgia (RR: 0.81; 95% CI: 0.32 - 2.03), or clinical deterioration (RR: 0.98; 95% CI: 0.58 - 1.67). Conclusions Statin treatment appears to be safe but may have no effect on PH. Pulmonary hypertension (PH) is a serious disease, and treatment is a continuing challenge. Some in vitro and in vivo studies identified that statins were effective for PH. However, results of some randomised controlled trials (RCTs) have been controversial. The objective of our study was to clarify whether statins are effective and safe for pulmonary hypertension. We systematically searched for eligible RCTs from PubMed, EMBASE, Web of Science, and the Cochrane Library during January 2016. Two reviewers independently extracted data. Standard mean differences (SMDs) and weighted mean differences (WMDs) with 95% confidence intervals (CIs) were estimated for continuous data (exercise capacity cardiac, pulmonary arterial pressure (PAP), cardiac index, and low-density lipoprotein (LDL)). Risk ratios (RRs) were estimated for dichotomous data (adverse events and clinical deterioration). A total of 496 patients from six RCTs were included. Low-density lipoprotein in the statin group decreased significantly compared with the placebo group (WMD = -22.79; 95% CI: -34.33 ∼ -11.24). However, we did not find a statistically significant effect on exercise capacity (SMD = 0.18; 95% CI: -0.34 - 0.71), PAP (WMD = -3.01; 95% CI: -8.68 - 2.65), or CI (WMD = -0.04; 95% CI: -0.15 - 0.23). Additionally, there was no difference between statins and placebo with respect to hepatic injury (RR: 1.12; 95% CI: 0.43 - 2.92), myalgia (RR: 0.81; 95% CI: 0.32 - 2.03), or clinical deterioration (RR: 0.98; 95% CI: 0.58 - 1.67). Statin treatment appears to be safe but may have no effect on PH." @default.
- W2519495511 created "2016-09-23" @default.
- W2519495511 creator A5011894732 @default.
- W2519495511 creator A5015335129 @default.
- W2519495511 creator A5022754674 @default.
- W2519495511 creator A5037384654 @default.
- W2519495511 creator A5038641400 @default.
- W2519495511 creator A5049983491 @default.
- W2519495511 creator A5055512367 @default.
- W2519495511 creator A5059415456 @default.
- W2519495511 date "2017-05-01" @default.
- W2519495511 modified "2023-09-27" @default.
- W2519495511 title "Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials" @default.
- W2519495511 cites W1866413456 @default.
- W2519495511 cites W1949536786 @default.
- W2519495511 cites W1968506780 @default.
- W2519495511 cites W1969722648 @default.
- W2519495511 cites W1975545701 @default.
- W2519495511 cites W1979604318 @default.
- W2519495511 cites W1984608205 @default.
- W2519495511 cites W2017315346 @default.
- W2519495511 cites W2019531218 @default.
- W2519495511 cites W2027820010 @default.
- W2519495511 cites W2028114049 @default.
- W2519495511 cites W2032902902 @default.
- W2519495511 cites W2044741008 @default.
- W2519495511 cites W2044989988 @default.
- W2519495511 cites W2068993397 @default.
- W2519495511 cites W2075075037 @default.
- W2519495511 cites W2079335526 @default.
- W2519495511 cites W2087443431 @default.
- W2519495511 cites W2091379117 @default.
- W2519495511 cites W2092022349 @default.
- W2519495511 cites W2098923148 @default.
- W2519495511 cites W2104825830 @default.
- W2519495511 cites W2113554645 @default.
- W2519495511 cites W2116961502 @default.
- W2519495511 cites W2117259028 @default.
- W2519495511 cites W2119436573 @default.
- W2519495511 cites W2124002852 @default.
- W2519495511 cites W2125435699 @default.
- W2519495511 cites W2129800911 @default.
- W2519495511 cites W2134053226 @default.
- W2519495511 cites W2138091764 @default.
- W2519495511 cites W2143132974 @default.
- W2519495511 cites W2155567491 @default.
- W2519495511 cites W2156389668 @default.
- W2519495511 cites W2157229294 @default.
- W2519495511 cites W2166964193 @default.
- W2519495511 cites W2183644045 @default.
- W2519495511 cites W250564224 @default.
- W2519495511 doi "https://doi.org/10.1016/j.hlc.2016.08.005" @default.
- W2519495511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27769753" @default.
- W2519495511 hasPublicationYear "2017" @default.
- W2519495511 type Work @default.
- W2519495511 sameAs 2519495511 @default.
- W2519495511 citedByCount "9" @default.
- W2519495511 countsByYear W25194955112017 @default.
- W2519495511 countsByYear W25194955112018 @default.
- W2519495511 countsByYear W25194955112019 @default.
- W2519495511 countsByYear W25194955112022 @default.
- W2519495511 countsByYear W25194955112023 @default.
- W2519495511 crossrefType "journal-article" @default.
- W2519495511 hasAuthorship W2519495511A5011894732 @default.
- W2519495511 hasAuthorship W2519495511A5015335129 @default.
- W2519495511 hasAuthorship W2519495511A5022754674 @default.
- W2519495511 hasAuthorship W2519495511A5037384654 @default.
- W2519495511 hasAuthorship W2519495511A5038641400 @default.
- W2519495511 hasAuthorship W2519495511A5049983491 @default.
- W2519495511 hasAuthorship W2519495511A5055512367 @default.
- W2519495511 hasAuthorship W2519495511A5059415456 @default.
- W2519495511 hasConcept C126322002 @default.
- W2519495511 hasConcept C142724271 @default.
- W2519495511 hasConcept C168563851 @default.
- W2519495511 hasConcept C197934379 @default.
- W2519495511 hasConcept C204787440 @default.
- W2519495511 hasConcept C27081682 @default.
- W2519495511 hasConcept C2776478404 @default.
- W2519495511 hasConcept C2776839432 @default.
- W2519495511 hasConcept C2778616394 @default.
- W2519495511 hasConcept C2780930700 @default.
- W2519495511 hasConcept C44249647 @default.
- W2519495511 hasConcept C535046627 @default.
- W2519495511 hasConcept C71924100 @default.
- W2519495511 hasConcept C82789193 @default.
- W2519495511 hasConcept C95190672 @default.
- W2519495511 hasConceptScore W2519495511C126322002 @default.
- W2519495511 hasConceptScore W2519495511C142724271 @default.
- W2519495511 hasConceptScore W2519495511C168563851 @default.
- W2519495511 hasConceptScore W2519495511C197934379 @default.
- W2519495511 hasConceptScore W2519495511C204787440 @default.
- W2519495511 hasConceptScore W2519495511C27081682 @default.
- W2519495511 hasConceptScore W2519495511C2776478404 @default.
- W2519495511 hasConceptScore W2519495511C2776839432 @default.
- W2519495511 hasConceptScore W2519495511C2778616394 @default.
- W2519495511 hasConceptScore W2519495511C2780930700 @default.
- W2519495511 hasConceptScore W2519495511C44249647 @default.
- W2519495511 hasConceptScore W2519495511C535046627 @default.